fludarabine has been researched along with Acute Kidney Injury in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brierley, CK; Eyre, TA | 1 |
| Calip, GS; Oh, AL; Patel, PR; Rondelli, D; Sweiss, K | 1 |
| Barba, P; Briones, J; Brunet, S; Delgado, J; Martino, R; Moreno, E; Piñana, JL; Sierra, J; Sureda, A; Valcárcel, D; Vega, M | 1 |
| Champlin, RE; de Lima, M; de Padua Silva, L; de Souza, JA; Efebera, Y; Hosing, C; Patah, P; Popat, U; Qazilbash, MH; Ribeiro, R; Rondon, G; Saliba, RM | 1 |
| Peterson, A; Shah, BK; Uprety, D | 1 |
| Basok, A; Mostoslavsky, M; Rogachev, B; Shnaider, A; Tovbin, D | 1 |
| Abecasis, M; da Costa, FL; Miranda, N; Nave, M; Nunes, R; Passos-Coelho, JL | 1 |
| Blume, KG; Edelstein, CL; Maloney, DG; Maris, MB; McSweeney, P; Nieto, Y; Parikh, CR; Sahebi, F; Sandmaier, BM; Schrier, RW; Storb, RF | 1 |
| Majumdar, G; Ramachandran, A | 1 |
| Lennard, AL; Osborne, WL | 1 |
| Diaconescu, R; Maloney, DG; Maris, MB; McSweeney, P; Parikh, CR; Sandmaier, BM; Schrier, RW; Sorror, ML; Storb, R; Storer, B | 1 |
| Czock, D; Hertenstein, B; Keller, F; Kielstein, JT; Radermacher, J; Stadler, M | 1 |
| Gouldesbrough, DR; Macheta, MP; Parapia, LA | 1 |
| Karadogan, I; Timuragaoglu, A; Undar, L | 1 |
| Crowley, S; Dahut, WL; Frame, JN | 1 |
1 review(s) available for fludarabine and Acute Kidney Injury
| Article | Year |
|---|---|
Renal failure secondary to leukemic infiltration of kidneys in CLL--a case report and review of literature.
Topics: Acute Kidney Injury; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Delayed Diagnosis; Humans; Kidney; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemic Infiltration; Lymph Nodes; Male; Renal Dialysis; Rituximab; Vidarabine | 2013 |
1 trial(s) available for fludarabine and Acute Kidney Injury
| Article | Year |
|---|---|
Renal dysfunction within 90 days of FluBu4 predicts early and late mortality.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Aged; Allografts; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Models, Biological; Retrospective Studies; Survival Rate; Vidarabine | 2019 |
13 other study(ies) available for fludarabine and Acute Kidney Injury
| Article | Year |
|---|---|
Acute monoblastic leukemia presenting with striking periorbital and periauricular infiltration.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Ear, External; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hearing Loss, Unilateral; Humans; Idarubicin; Leukemia, Monocytic, Acute; Leukemic Infiltration; Male; Orbit; Tumor Lysis Syndrome; Vidarabine | 2017 |
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Cyclosporine; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Melphalan; Methotrexate; Middle Aged; Mycophenolic Acid; Premedication; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation; Young Adult | 2009 |
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.
Topics: Acute Kidney Injury; Adult; Aged; Glomerular Filtration Rate; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Remission Induction; Retrospective Studies; Transplantation Conditioning; Vidarabine; Young Adult | 2009 |
Severe hypoglycemia in a patient with acute renal failure due to tumor lysis syndrome.
Topics: Acute Kidney Injury; Antineoplastic Agents; Female; Humans; Hypoglycemia; Leukemia, Lymphoid; Middle Aged; Severity of Illness Index; Tumor Lysis Syndrome; Vidarabine | 2002 |
Reversible acute renal failure following single administration of fludarabine.
Topics: Acute Kidney Injury; Adult; Antineoplastic Agents; Combined Modality Therapy; Hodgkin Disease; Humans; Immunosuppressive Agents; Male; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2004 |
Acute renal failure after nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adult; Aged; Behavior Therapy; Cohort Studies; Cyclosporine; Female; Glomerular Filtration Rate; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Stem Cell Transplantation; Tacrolimus; Time Factors; Vidarabine | 2004 |
Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia.
Topics: Acute Kidney Injury; Administration, Oral; Disease Progression; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Tumor Lysis Syndrome; Vidarabine | 2004 |
Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to Alemtuzumab (Campath 1H) or fludarabine.
Topics: Acute Kidney Injury; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chronic Disease; Disseminated Intravascular Coagulation; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Renal Dialysis; Transplantation Conditioning; Vidarabine | 2005 |
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Busulfan; Cohort Studies; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Patient Selection; Postoperative Complications; Recurrence; Renal Dialysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2005 |
Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure.
Topics: Acute Kidney Injury; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Renal Dialysis; Vidarabine | 2005 |
Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine.
Topics: Acute Kidney Injury; Antineoplastic Agents; Glomerulonephritis, Membranoproliferative; Humans; Kidney Glomerulus; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Vidarabine | 1995 |
Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine.
Topics: Acute Kidney Injury; Antimetabolites, Antineoplastic; Autoantibodies; Erythrocytes; Fatal Outcome; Glomerulonephritis; Humans; Immune Complex Diseases; Kidney Failure, Chronic; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Renal Dialysis; Salvage Therapy; Vidarabine | 1999 |
Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.
Topics: Acute Kidney Injury; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Tumor Lysis Syndrome; Vidarabine | 1992 |